Orexo
Develops pharmaceuticals and digital therapies for substance use and mental health.
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
Description
Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-06-30 08:00 |
Orexo tecknar licensavtal som ger Mundipharma globala rättigheter till Zubsolv®…
|
Swedish | 325.4 KB | ||
| 2016-06-30 08:00 |
Orexo signs license agreement with Mundipharma, which obtains ex-US global righ…
|
English | 328.9 KB | ||
| 2016-06-21 18:30 |
Orexo sees very limited exposure to the UK and the British pound
|
English | 332.5 KB | ||
| 2016-06-21 18:30 |
Orexos exponering mot UK och det brittiska pundet är ytterst begränsad
|
Swedish | 331.1 KB | ||
| 2016-05-31 17:30 |
Orexo to present at Jefferies 2016 Healthcare Conference, NYC
|
English | 213.8 KB | ||
| 2016-05-31 17:30 |
Orexo deltar i Jefferies 2016 Healthcare Conference, NYC
|
Swedish | 212.6 KB | ||
| 2016-04-21 12:00 | Swedish | 1.3 MB | |||
| 2016-04-21 12:00 | English | 1.3 MB | |||
| 2016-04-21 08:00 |
Interim Report January-March 2016
|
English | 1.4 MB | ||
| 2016-04-21 08:00 |
Delårsrapport januari-mars 2016
|
Swedish | 1.3 MB | ||
| 2016-04-15 19:30 |
Kommuniké från Orexo AB:s årsstämma den 15 april 2016
|
Swedish | 328.7 KB | ||
| 2016-04-15 19:30 |
Report from Orexo AB’s Annual General Meeting, 15 April 2016
|
English | 333.9 KB | ||
| 2016-03-22 11:45 |
Orexo’s Annual Report for 2015 released
|
English | 3.0 MB | ||
| 2016-03-22 11:45 |
Orexos årsredovisning för 2015 offentliggjord
|
Swedish | 3.0 MB | ||
| 2016-03-18 16:02 | English | 34.8 KB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orexo
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
Peer Companies
